Pharmabiz5h
FABA inks MoU with Thu Dau Mot University to set up FABA chapter in Vietnam
FABA inks MoU with Thu Dau Mot University to set up FABA chapter in Vietnam: Our Bureau, Bengaluru Wednesday, September 25, ...
Pharmabiz59m
LEO Pharma’s Anzupgo cream receives European marketing approval for adults with moderate to severe chronic hand eczema
LEO Pharma A/S, a global leader in medical dermatology, announced that the European Commission (EC) has granted marketing authorization for Anzupgo (delgocitinib) cream for the treatment of adult ...
Pharmabiz1h
Experts highlight urgent need for novel anti-infectives at the 7th Annual National Conference by Society of Neurocritical Care of India
Our Bureau, Mumbai Wednesday, September 25, 2024, 17:50 Hrs [IST] ...
Pharmabiz1h
Theriva achieves target patient enrollment in VIRAGE phase 2b trial of VCN-01 with gemcitabine/nab-paclitaxel to treat metastatic pancreatic cancer
Rockville, Maryland Wednesday, September 25, 2024, 18:00 Hrs [IST] ...
Pharmabiz2h
Chugai receives Japanese additional indication approval for Evrysdi in pre-symptomatic SMA and additional dosage for infants under 2 months of age
Chugai receives Japanese additional indication approval for Evrysdi in pre-symptomatic SMA and additional dosage for infants under 2 months of age: Tokyo Wednesday, September 25, ...
Pharmabiz2h
Narayana Health sets its first-of-its-kind robotic cardiac centre of excellence
Narayana Health sets its first-of-its-kind robotic cardiac centre of excellence: Our Bureau, Bengaluru Wednesday, September 25, 2024, 17:40 Hrs [IST] Narayana Health, unveiled fir ...
Pharmabiz2h
Emmes awarded multi-task, IDIQ contract
Emmes, part of Emmes Group, a leading specialty tech-enabled global contract research organization (CRO), has been selected by the National Institutes of Health’s (NIH) NIDA [National Institute of ...
Pharmabiz11h
Health ministry notifies Rules to register CROs under NDCTR, 2019
Health ministry notifies Rules to register CROs under NDCTR, 2019: Gireesh Babu, New Delhi Wednesday, September 25, 2024, ...
Pharmabiz4h
Aileron Therapeutics completes patient enrollment in Cohort 2 of phase 1b trial of LTI-03 in idiopathic pulmonary fibrosis
Aileron Therapeutics completes patient enrollment in Cohort 2 of phase 1b trial of LTI-03 in idiopathic pulmonary fibrosis: Austin, Texas Wednesday, September 25, 2024, 15:00 Hrs ...
Pharmabiz3h
Takeda receives Japanese nod to manufacture and market Fruzaqla to treat unresectable advanced or recurrent colorectal cancer
Takeda receives Japanese nod to manufacture and market Fruzaqla to treat unresectable advanced or recurrent colorectal cancer: Osaka, Japan Wednesday, September 25, 2024, 16:30 Hr ...
Pharmabiz3h
NIH awards $27 million to establish new network of genomics-enabled learning health systems
NIH awards $27 million to establish new network of genomics-enabled learning health systems: Bethesda, Maryland Wednesday, September 25, 2024, 16:00 Hrs [IST] The National Institu ...
Pharmabiz4h
Cactus and Gubbi Labs report identifies key opportunities for innovation, international collaboration, & investment in biopharma
Cactus and Gubbi Labs report identifies key opportunities for innovation, international collaboration, & investment in biopharma: Our Bureau, Bengaluru Wednesday, September 25, 20 ...